Valensa has updated its USPlus logo following the research review
A recent scientific review of clinical research on lipidosterolic extracts of saw palmetto has reinforced Valensa’s approach to the ingredient, the company says.
The review says a quality lipidosterolic extract of saw palmetto improves prostate health and quality of life for men with lower urinary tract symptoms (LUTS).
Clinical studies suggest the effective dose of saw palmetto is 320 mg per day, and that dried berry powder supplements do not have the lipid profile to be beneficial.
USPlus is a lipidosterolic extract verified by US Pharmacopeia to contain the required fatty acids, phytosterols, and other phytonutrients required for a quality prostate health product.
In the redesign of the USPlus logo, Valensa has incorporated purple colouring in reference to the company’s use of ripe berries, which are purple in colour and will deliver the right lipid profile, it claims.
“Our commitment to harvesting ripe berries, and use of our DeepExtract supercritical CO2 technology to capture all the important lipid compounds into the finished product, USPlus, is now reflected in the logo,” said Stephen Hill, VP, Product Development, Quality, and Regulatory Affairs for Valensa.
An effective saw palmetto supplement is a lipid extract, not crushed dried berry powder, with a deep colour reflecting the presence of key lipid compounds, according to Hill.
Valensa CEO Umasudhan Pal said: “We updated the logo to reflect our expertise and leadership from harvest through the manufacturing and extraction process. For USPlus, it’s critical to distinguish the difference between the effectiveness of a lipidosterolic extract of saw palmetto from ripe berries to the ineffective crushed berry powder supplements.”